Literature DB >> 29661944

Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.

Lin Y Chen, Mina K Chung, Larry A Allen, Michael Ezekowitz, Karen L Furie, Pamela McCabe, Peter A Noseworthy, Marco V Perez, Mintu P Turakhia.   

Abstract

Our understanding of the risk factors and complications of atrial fibrillation (AF) is based mostly on studies that have evaluated AF in a binary fashion (present or absent) and have not investigated AF burden. This scientific statement discusses the published literature and knowledge gaps related to methods of defining and measuring AF burden, the relationship of AF burden to cardiovascular and neurological outcomes, and the effect of lifestyle and risk factor modification on AF burden. Many studies examine outcomes by AF burden classified by AF type (paroxysmal versus nonparoxysmal); however, quantitatively, AF burden can be defined by longest duration, number of AF episodes during a monitoring period, and the proportion of time an individual is in AF during a monitoring period (expressed as a percentage). Current guidelines make identical recommendations for anticoagulation regardless of AF pattern or burden; however, a review of recent evidence suggests that higher AF burden is associated with higher risk of stroke. It is unclear whether the risk increases continuously or whether a threshold exists; if a threshold exists, it has not been defined. Higher burden of AF is also associated with higher prevalence and incidence of heart failure and higher risk of mortality, but not necessarily lower quality of life. A structured and comprehensive risk factor management program targeting risk factors, weight loss, and maintenance of a healthy weight appears to be effective in reducing AF burden. Despite this growing understanding of AF burden, research is needed into validation of definitions and measures of AF burden, determination of the threshold of AF burden that results in an increased risk of stroke that warrants anticoagulation, and discovery of the mechanisms underlying the weak temporal correlations of AF and stroke. Moreover, developments in monitoring technologies will likely change the landscape of long-term AF monitoring and could allow better definition of the significance of changes in AF burden over time.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  AHA Scientific Statements; atrial fibrillation; lifestyle; risk factors; stroke

Mesh:

Substances:

Year:  2018        PMID: 29661944     DOI: 10.1161/CIR.0000000000000568

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  75 in total

Review 1.  Population-Based Screening for Atrial Fibrillation.

Authors:  Shaan Khurshid; Jeffrey S Healey; William F McIntyre; Steven A Lubitz
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Secular trends in success rate of catheter ablation for atrial fibrillation: The SMASH-AF cohort.

Authors:  Alexander C Perino; George C Leef; Andrew Cluckey; Fahd N Yunus; Mariam Askari; Paul A Heidenreich; Sanjiv M Narayan; Paul J Wang; Mintu P Turakhia
Journal:  Am Heart J       Date:  2018-10-29       Impact factor: 4.749

Review 3.  Complexities in the Atrial Fibrillation-Stroke Relationship: Improving Comprehension of Temporal Discordance, Magnitude Synergism, and Subclinical Atrial Fibrillation -- Three Sources of Consternation for Physicians Who Care for Patients with Atrial Fibrillation.

Authors:  James A Reiffel
Journal:  J Atr Fibrillation       Date:  2018-08-31

4.  Catheter ablation: an ongoing revolution.

Authors:  Alexandre Raymond-Paquin; Jason Andrade; Laurent Macle
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

5.  Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.

Authors:  Alexander C Perino; Jun Fan; Mariam Askari; Paul A Heidenreich; Edmund Keung; Merritt H Raitt; Jonathan P Piccini; Paul D Ziegler; Mintu P Turakhia
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

6.  2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society.

Authors:  Niraj Varma; Iwona Cygankiewicz; Mintu P Turakhia; Hein Heidbuchel; Yu-Feng Hu; Lin Yee Chen; Jean-Philippe Couderc; Edmond M Cronin; Jerry D Estep; Lars Grieten; Deirdre A Lane; Reena Mehra; Alex Page; Rod Passman; Jonathan P Piccini; Ewa Piotrowicz; Ryszard Piotrowicz; Pyotr G Platonov; Antonio Luiz Ribeiro; Robert E Rich; Andrea M Russo; David Slotwiner; Jonathan S Steinberg; Emma Svennberg
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-12

7.  TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): A Randomized Clinical Trial.

Authors:  Stavros Stavrakis; Julie A Stoner; Mary Beth Humphrey; Lynsie Morris; Adrian Filiberti; Justin C Reynolds; Khaled Elkholey; Isma Javed; Nicholas Twidale; Pavel Riha; Subha Varahan; Benjamin J Scherlag; Warren M Jackman; Tarun W Dasari; Sunny S Po
Journal:  JACC Clin Electrophysiol       Date:  2020-01-29

Review 8.  Carotid Atherosclerosis in Patients with Atrial Fibrillation.

Authors:  Zhaojia Wang; Panagiotis Korantzopoulos; Tong Liu
Journal:  Curr Atheroscler Rep       Date:  2019-11-29       Impact factor: 5.113

Review 9.  Stroke prevention strategies in high-risk patients with atrial fibrillation.

Authors:  Agnieszka Kotalczyk; Michał Mazurek; Zbigniew Kalarus; Tatjana S Potpara; Gregory Y H Lip
Journal:  Nat Rev Cardiol       Date:  2020-10-27       Impact factor: 32.419

10.  Implications of Atrial Fibrillation Among Patients With Atherosclerotic Cardiovascular Disease Undergoing Noncardiac Surgery.

Authors:  Rajat Kalra; Vibhu Parcha; Nirav Patel; Anirudh Bhargava; Peng Li; Garima Arora; Pankaj Arora
Journal:  Am J Cardiol       Date:  2020-04-12       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.